Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1325-1328

  McClenny, Nancy B ^a   Fei, Haihua ^a   Baron, Ellen J ^a   Gales, Ana C ^a   Houston, Allison ^a   Hollis, Richard J ^a   Pfaller, Michael A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CANDIDA LUSITANIAE; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; COLONY FORMATION; DIAGNOSTIC KIT; DISEASE COURSE; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; SEPSIS;

AGED; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; BLOOD; CANDIDA; CANDIDIASIS; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; DRUG RESISTANCE, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FATAL OUTCOME; FEMALE; FUNGEMIA; HUMANS; MICROBIAL SENSITIVITY TESTS; TREATMENT FAILURE;

EID: 0036235523     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1325-1328.2002     Document Type: Article

References (18)

1. Emergence of a new opportunistic pathogen, Candida lusitaniae
2. Candida lusitaniae: An emerging human pathogen
3. Fetal septicemia due to amphotericin B-resistant Candida lusitaniae
4. Mycosis caused by Candida lusitaniae
5. New and emerging yeast pathogens
6. Comparison of four DNA-based methods for strain delineation of Candida lusitaniae
7. The genotypic relationship of Candida albicans strains isolated from the oral cavity of patients with denture stomatitis
8. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus
9. Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis
10. Candida lusitaniae: Frequency of recovery, colonization, infection, and amphotericin B resistance
11. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae
12. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species
13. Development of resistance to amphotericin B in Candida lusitaniae infecting a human
14. Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae
15. Amphotericin B-resistant yeast infection in severely immunocompromised patients
16. Epidemiology of nosocomial acquisition of Candida lusitaniae
17. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance